Galectin Therapeutics Inc (GALT)
2.78
+0.06
(+2.21%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
-0.01
(-0.36%)
After-Hours: 20:00
Galectin Therapeutics Total Liabilities (Quarterly): 121.45M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 121.45M |
| June 30, 2024 | 109.80M |
| March 31, 2024 | 96.98M |
| December 31, 2023 | 88.44M |
| September 30, 2023 | 73.04M |
| June 30, 2023 | 71.21M |
| March 31, 2023 | 62.87M |
| December 31, 2022 | 53.48M |
| September 30, 2022 | 40.25M |
| June 30, 2022 | 41.11M |
| March 31, 2022 | 39.81M |
| December 31, 2021 | 39.21M |
| September 30, 2021 | 28.79M |
| June 30, 2021 | 16.29M |
| March 31, 2021 | 4.663M |
| December 31, 2020 | 5.407M |
| September 30, 2020 | 2.507M |
| June 30, 2020 | 4.306M |
| March 31, 2020 | 1.358M |
| December 31, 2019 | 2.872M |
| September 30, 2019 | 1.278M |
| June 30, 2019 | 1.391M |
| March 31, 2019 | 0.988M |
| December 31, 2018 | 2.108M |
| September 30, 2018 | 1.646M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.435M |
| March 31, 2018 | 2.283M |
| December 31, 2017 | 2.968M |
| September 30, 2017 | 4.341M |
| June 30, 2017 | 3.512M |
| March 31, 2017 | 4.362M |
| December 31, 2016 | 3.78M |
| September 30, 2016 | 4.087M |
| June 30, 2016 | 3.636M |
| March 31, 2016 | 3.25M |
| December 31, 2015 | 1.36M |
| September 30, 2015 | 1.726M |
| June 30, 2015 | 1.908M |
| March 31, 2015 | 1.291M |
| December 31, 2014 | 1.703M |
| September 30, 2014 | 1.38M |
| June 30, 2014 | 2.147M |
| March 31, 2014 | 1.937M |
| December 31, 2013 | 2.486M |
| September 30, 2013 | 1.604M |
| June 30, 2013 | 1.498M |
| March 31, 2013 | 1.473M |
| December 31, 2012 | 1.644M |
| September 30, 2012 | 8.136M |
| June 30, 2012 | 8.416M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.358M
Minimum
Mar 2020
121.45M
Maximum
Sep 2024
45.19M
Average
40.03M
Median
Total Liabilities (Quarterly) Benchmarks
| Microbot Medical Inc | 1.40M |
| Alaunos Therapeutics Inc | 0.826M |
| SELLAS Life Sciences Group Inc | 10.61M |
| Oragenics Inc | 2.126M |
| Anavex Life Sciences Corp | 11.75M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.97M |
| Shareholders Equity (Quarterly) | -92.48M |